Watchful waiting, not drugs, encouraged for otitis media

Demystifying PBMs, Their Role in the Drug Supply Chain

Guselkumab is the first and only IL-23 inhibitor to demonstrate robust data as a fully subcutaneous regimen.

Brian Nowosielski;Antonio Ciaccia

Bemnifosbuvir, Ruzasvir Regimen Shows Strong Efficacy as HCV Treatment

President of 3 Axis Advisors and CEO of 46brooklyn Research joins Drug Topics to discuss nuances surrounding pharmacy benefit managers and the way they are perceived in the public eye.

Killian Meara

Scripted for Her: Helping Patients Choose Contraceptive Methods

A phase 2 study found 95% of patients achieved a sustained virologic response at 12 weeks regardless of treatment adherence.

Killian Meara;Natalie DiPietro Mager, PharmD, PhD;Jasmine Cutler, PharmD, CPh

Demystify Your Purchasing Plan

In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.

AAP Members are Nationally Recognized Community Leaders

Tremfya Demonstrates Sustained Response Up to 92 Weeks

Related Content

Ashley Gallagher

Demystifying PBMs, Their Role in the Drug Supply Chain

Guselkumab is the first and only IL-23 inhibitor to demonstrate robust data as a fully subcutaneous regimen.

Brian Nowosielski;Antonio Ciaccia

Bemnifosbuvir, Ruzasvir Regimen Shows Strong Efficacy as HCV Treatment

President of 3 Axis Advisors and CEO of 46brooklyn Research joins Drug Topics to discuss nuances surrounding pharmacy benefit managers and the way they are perceived in the public eye.

Killian Meara

Scripted for Her: Helping Patients Choose Contraceptive Methods

A phase 2 study found 95% of patients achieved a sustained virologic response at 12 weeks regardless of treatment adherence.

Killian Meara;Natalie DiPietro Mager, PharmD, PhD;Jasmine Cutler, PharmD, CPh

Demystify Your Purchasing Plan

In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.